3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 1/2
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
18
Neoplasms
14
Ovarian Neoplasms
7
Lung Neoplasms
7
Leukemia, Myeloid, Acute
7
Lymphoma
6
Neoplasm Metastasis
5
Multiple Myeloma
5
Hematologic Neoplasms
5
Prostatic Neoplasms
4
Leukemia
4
Glioblastoma
4
Fatigue
4
Colorectal Neoplasms
4
Vulvar Neoplasms
3
Uterine Cervical Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Myelodysplastic Syndromes
3
Depression
3
Anxiety Disorders
3
Vaginal Neoplasms
2
Urinary Bladder Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Peritoneal Neoplasms
2
Pain
2
Motor Activity
2
Melanoma
2
Interventions
Radiosurgery
28
Magnetic Resonance Spectroscopy
27
Dexmedetomidine
8
Radiotherapy
7
Radiation
7
Proton Therapy
7
Mental Status and Dementia Tests
7
Magnetic Resonance Imaging
7
Exercise
6
Surgical Procedures, Operative
5
Specimen Handling
5
Saline Solution
5
Blood Specimen Collection
5
Bevacizumab
5
Remifentanil
4
Radiotherapy, Intensity-Modulated
4
Propofol
4
alovudine
3
Transcranial Magnetic Stimulation
3
Temozolomide
3
Resistance Training
3
Methods
3
Mannitol
3
Diffusion Tensor Imaging
3
Cognitive Training
3
gadobutrol
2
gadobenic acid
2
Yoga
2
Vitamin D
2
Ultrasonography
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Brain Neoplasms
×
Palliative Care
×
Clear all
NCT07590726
2026-05-19
PIRe
Rigshospitalet, Denmark
Phase NA
Not yet recruiting
160 enrolled